共 50 条
Transplant of SARS-CoV-2-infected Living Donor Liver: Case Report
被引:13
|作者:
Nguyen, Michelle C.
[1
]
Lee, Eliza J.
[1
]
Avery, Robin K.
[2
]
Dioverti-Prono, M. Veronica
[2
]
Shoham, Shmuel
[2
]
Tobian, Aaron A. R.
[3
]
Bloch, Evan M.
[3
]
Gurakar, Ahmet
[4
]
Rizkalla, Nicole A.
[5
]
Cameron, Andrew M.
[1
,6
]
King, Elizabeth A.
[1
]
Ottmann, Shane
[1
]
Garonzik-Wang, Jacqueline M.
[1
,6
]
Wesson, Russel N.
[1
]
Philosophe, Benjamin
[1
]
机构:
[1] Johns Hopkins Univ, Sch Med, Dept Surg, Div Transplant Surg, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Dept Med, Div Infect Dis, Baltimore, MD 21205 USA
[3] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA
[4] Johns Hopkins Univ, Sch Med, Dept Med, Div Gastroenterol & Hepatol, Baltimore, MD 21205 USA
[5] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA
[6] Johns Hopkins Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
来源:
关键词:
SOLID-ORGAN TRANSPLANTATION;
EARLY IMPACT;
COVID-19;
D O I:
10.1097/TXD.0000000000001178
中图分类号:
R3 [基础医学];
R4 [临床医学];
学科分类号:
1001 ;
1002 ;
100602 ;
摘要:
Given the high community prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), transplant programs will encounter SARS-CoV-2 infections in living donors or recipients in the perioperative period. There is limited data on SARS-CoV-2 viremia and organotropism beyond the respiratory tract to inform the risk of transplant transmission of SARS-CoV-2. We report a case of a living donor liver transplant recipient who received a right lobe graft from a living donor with symptomatic PCR-confirmed SARS-CoV-2 infection 3 d following donation. The donor was successfully treated with remdesivir, dexamethasone, and coronavirus disease 2019 (COVID-19) convalescent plasma. No viral transmission was identified, and both donor and recipient had excellent postoperative outcomes.
引用
下载
收藏
页数:5
相关论文